SISCAPA Assay Technologies

About:

SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets.

Website: http://siscapa.com

Twitter/X: siscapa

Description:

SISCAPA Assay Technologies, Inc. develops SISCAPA assays for high-value protein biomarkers and other proteins to enable precise measurement of human protein in clinical and other samples. The company offers SISCAPA assay reagents, including RabMAb, which are rabbit monoclonal anti-peptide antibodies; and isotope standard labeled peptides, unlabelled peptides, and magnetic beads for protein biomarkers. Its products are also used in commercial applications. The company provides SISCAPA licenses the technology to use for commercial research purposes, or to commercialize SISCAPA reagents; and kits or assay services. SISCAPA Assay Technologies, Inc. was incorporated in 2011 and is based in Washin...

Total Funding Amount:

$1.56M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Washington, California, United States

Founded Date:

2011-01-01

Contact Email:

contact(AT)SISCAPA.com

Founders:

Leigh Anderson, Terry W. Pearson

Number of Employees:

11-50

Last Funding Date:

2014-04-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai